Evidence map›Paper›PMID 25734072›Full record

ArticleCold Spring Harbor protocols2015

The estrogen receptor fusion system in mouse models: a reversible switch.

Jonathan Whitfield, Trevor Littlewood, Gerard I Evan, Laura Soucek

Open access · greenAbstract read
In one paragraph

Article in Cold Spring Harbor protocols, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Advances in Immunocompetent Mouse and Rat Models.Cold Spring Harbor perspectives in medicine · 2024
    Review
  6. Article
  7. Review
  8. Mouse models of diffuse large B cell lymphoma.Frontiers in immunology · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Cyanine Photocages Enable Spatial Control of Inducible Cre-Mediated Recombination.Chembiochem : a European journal of chemical biology · 2018
    Article
  14. Review
  15. Article
  16. Tamoxifen administration to mice.Cold Spring Harbor protocols · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Jonathan WhitfieldVall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain; Universitat Autònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès), Spain;
Trevor LittlewoodDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom.
Gerard I EvanDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom.
Laura SoucekVall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain; Universitat Autònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès), Spain;
University of Cambridge · GBUniversitat Autònoma de Barcelona · ESVall d'Hebron Institute of Oncology

Funding

European Research Council 617473
6 · The paper itself

Abstract

Reversible regulatory mouse models have significantly contributed to our understanding of normal tissue and cancer biology, providing the opportunity to temporally control initiation, progression, and evolution of physiological and pathological events. The tamoxifen inducible system, one of the best-characterized "reversible switch" models, has a number of beneficial features. In this system, the hormone-binding domain of the mammalian estrogen receptor is used as a heterologous regulatory domain. Upon ligand binding, the receptor is released from its inhibitory complex and the fusion protein becomes functional. We summarize the advantages and drawbacks of the system, describe several mouse models that rely on it, and discuss potential improvements that could render it even more useful and versatile.

Indexed as

AnimalsGene Expression RegulationMiceModels, AnimalReceptors, EstrogenRecombinant Fusion ProteinsTamoxifenReceptors, EstrogenRecombinant Fusion ProteinsTamoxifen

Identifiers

PMID25734072
PMCPMC6768801
OpenAlexW2043447291

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.